Company Search:
Advanced Search
Sponsored Links
Clal Biotechnology Industries Limited Company Snapshot
Clal Biotechnology Industries Limited operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Clal Biotechnology Industries Limited with three other companies in this sector in Israel: Evogene Limited (2017 sales of 12.07 million Israel Shekels [US$3.32 million] of which 96% was Agricultural Crops), Redhill Biopharma Ltd (14.31 million Israel Shekels [US$3.93 million] ), and Arcturus Therapeutics Ltd (46.42 million Israel Shekels [US$12.76 million] of which 100% was Pharmaceutical).

Sales Analysis. Clal Biotechnology Industries Limited reported sales of 54.50 million Israel Shekels (US$14.98 million) for the year ending December of 2017. This represents an increase of 118.0% versus 2016, when the company's sales were 25.01 million Israel Shekels. Sales of Kayortech saw an increase that was more than double the company's growth rate: sales were up 669.6% in 2017, from 16.89 million Israel Shekels to 129.97 million Israel Shekels. Clal Biotechnology Industries Limited also saw significant increases in sales in Other (up 377.8% to 29.21 million Israel Shekels) . Not all segments of Clal Biotechnology Industries Limited experienced an increase in sales in 2017: sales of Medivned fell 21.7% to 11.58 million Israel Shekels.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Clal Biotechnology Industries Limited
  Stock Performance Chart for Clal Biotechnology Industries Limited
  Stock Data: Recent Stock Performance:
  Current Price (2/7/2019): 3.05
(Figures in Israel Shekels)
1 Week -1.4%   13 Weeks 13.8%  
4 Weeks -5.3%   52 Weeks -5.8%  
Clal Biotechnology Industries Limited Key Data:
  Ticker: CBI Country: Israel
  Exchanges: TEL Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 54,499,000
(Year Ending Jan 2018).
Employees: 123
  Currency: Israel Shekels Market Cap: 491,769,132
  Fiscal Yr Ends: December Shares Outstanding: 161,235,781
  Share Type: Ordinary Closely Held Shares: 101,303,398
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.